Darmiyan

Early detection of Alzheimer's disease

Y CombinatorSummer 2017ActiveHealthcareDiagnosticsArtificial IntelligenceMachine LearningHealth TechDiagnostics

What they do

Problem

Alzheimer's disease is often detected too late due to limited early, non-invasive diagnostic methods.

Solution

Darmiyan uses quantitative virtual microscopy software to analyze non-invasive MRI scans for early detection of Alzheimer's disease.

Who it's for

Hospitals, clinics, and research organizations that perform brain MRI imaging and assess patients for Alzheimer's risk.

Founders

Padideh Kamali-Zare

Founder

I'm Padideh — brain enthusiast, data driven, and one of the brains behind Darmiyan. After my Ph.D. in Biological Physics from KTH (Sweden) and postdoc in computational neuroscience at NYU (New York), I dove headfirst into the startup world to tackle a cause close to my heart: Alzheimer's. I've been on a mission to outsmart this disease since my grandmother's diagnosis. BrainSee is our first product that catches Alzheimer's early and give people a fighting chance.